Results from three ground-breaking cancer studies show early
A member of the executive committee for the 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics that is taking place in Munich, Germany, told the meeting today (Thursday): "We are seeing an important shift in oncology as we move from a one-treatment-fits-all approach to an era of personalised medicine for cancer. In this new era it is essential to discover novel, targeted drugs and to identify the patients most likely to benefit from them. This is highlighted at this meeting by several new drugs that show dramatic efficacy in patients with very advanced disease who have failed standard therapies. These drugs can be developed rapidly, based on trials involving relatively small numbers of patients....

http://medicalxpress.com/news/2016-11-results-ground-breaking-cancer-early-benefit.html
Like
Comment
Share